Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,960,000 | 6,817,300 | 3,084,300 | 6,536,200 | 3,724,300 |
| Marketable Securities | 76,100 | 92,200 | 1,705,200 | 1,497,900 | 3,218,800 |
| Receivables | 5,652,600 | 5,579,100 | 5,270,700 | 5,262,200 | 5,014,500 |
| Inventories | 4,118,000 | 4,155,500 | 4,631,300 | 4,458,300 | 4,406,900 |
| TOTAL | $20,685,900 | $18,332,700 | $16,261,500 | $19,202,100 | $17,428,400 |
| Non-Current Assets | |||||
| PPE Net | 8,814,100 | 8,770,800 | 8,958,200 | 8,826,500 | 8,598,500 |
| Investments And Advances | 2,005,800 | 2,059,600 | 5,375,100 | 5,678,800 | 6,148,700 |
| Intangibles | 3,619,400 | 3,772,100 | 3,920,000 | 4,029,200 | 4,271,600 |
| Other Non-Current Assets | 9,499,900 | 9,424,000 | 9,840,800 | 7,244,400 | 6,563,200 |
| TOTAL | $23,939,200 | $24,026,500 | $28,094,100 | $25,778,900 | $25,582,000 |
| Total Assets | $44,625,100 | $42,359,200 | $44,355,600 | $44,981,000 | $43,010,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,281,200 | 1,316,900 | 1,267,400 | 1,410,700 | 1,200,100 |
| Other current liabilities | 8,134,100 | 7,646,100 | 7,282,400 | 8,295,100 | 7,513,900 |
| TOTAL | $10,826,700 | $13,055,200 | $11,547,000 | $14,535,900 | $12,666,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,674,700 | 9,170,500 | 9,393,500 | 9,940,500 | 9,926,600 |
| Other Non-Current Liabilities | 7,972,800 | 8,512,700 | 8,827,300 | 8,836,700 | 5,456,700 |
| TOTAL | $19,647,500 | $17,683,200 | $18,220,800 | $18,777,200 | $15,383,300 |
| Total Liabilities | $30,474,200 | $30,738,400 | $29,767,800 | $33,313,100 | $28,049,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,059,322 | 1,073,988 | 1,085,430 | 1,095,598 | 1,101,095 |
| Common Shares | 667,100 | 673,500 | 680,800 | 687,900 | 688,500 |
| Retained earnings | 14,408,700 | 14,247,300 | 16,608,200 | 13,894,100 | 16,145,500 |
| Other shareholders' equity | -7,378,800 | -9,056,700 | -8,390,200 | -8,655,900 | -7,552,100 |
| TOTAL | $14,150,900 | $11,620,800 | $14,587,800 | $11,667,900 | $14,960,600 |
| Total Liabilities And Equity | $44,625,100 | $42,359,200 | $44,355,600 | $44,981,000 | $43,010,400 |